3 minute read4/1/2016animal
An animal model study where BPC‑157 improved liver recovery metrics and mitigated the worsening effects of nitric oxide synthase inhibition after major hepatic resection in rats.
What the study reported
BPC‑157 administration was associated with improved liver outcomes and counteraction of L‑NAME‑induced worsening in this rodent model.
How to read it carefully
Animal surgical model; results require validation and clinical translation.
Research context only. This brief summarizes a published source and does not establish clinical efficacy, safety, dosing, or suitability for human or veterinary use. Review the original paper before drawing conclusions.
Read the original source · Gastroenterology